Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Apremilast may help treat hair loss in alopecia areata.

Alopecia areata negatively affects the self-esteem and quality of life of children and teens.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

JAK inhibitors show promise for treating Alopecia Areata, but more research is needed for better, accessible treatments.

Some children may develop hair loss after having COVID-19.

A girl with severe hair loss saw hair regrowth after using cannabis.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

Herbal medicine might be a good alternative for treating hair loss.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

A Cavalier King Charles Spaniel had both uveodermatological syndrome and alopecia areata, and treatment with ciclosporin helped regrow hair.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

More research is needed to understand and treat morphea effectively.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.